Literature DB >> 11977762

[The cellular receptor for measles virus].

Y Yanagi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11977762

Source DB:  PubMed          Journal:  Uirusu        ISSN： 0042-6857


× No keyword cloud information.
  3 in total

1.  Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

Authors:  Evanthia Galanis; Lynn C Hartmann; William A Cliby; Harry J Long; Prema P Peethambaram; Brigitte A Barrette; Judith S Kaur; Paul J Haluska; Ileana Aderca; Paula J Zollman; Jeff A Sloan; Gary Keeney; Pamela J Atherton; Karl C Podratz; Sean C Dowdy; C Robert Stanhope; Timothy O Wilson; Mark J Federspiel; Kah-Whye Peng; Stephen J Russell
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

Review 2.  Review: Oncolytic virotherapy, updates and future directions.

Authors:  Christos Fountzilas; Sukeshi Patel; Devalingam Mahalingam
Journal:  Oncotarget       Date:  2017-05-31

3.  Oncolytic measles virus strains have significant antitumor activity against glioma stem cells.

Authors:  C Allen; M Opyrchal; I Aderca; M A Schroeder; J N Sarkaria; E Domingo; M J Federspiel; E Galanis
Journal:  Gene Ther       Date:  2012-08-23       Impact factor: 5.250
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.